Brain neurotransmitter receptor-binding characteristics in rats after oral administration of haloperidol, risperidone and olanzapine.

Article Details

Citation

Uchida S, Kato Y, Hirano K, Kagawa Y, Yamada S

Brain neurotransmitter receptor-binding characteristics in rats after oral administration of haloperidol, risperidone and olanzapine.

Life Sci. 2007 Apr 3;80(17):1635-40. Epub 2007 Jan 27.

PubMed ID
17316700 [ View in PubMed
]
Abstract

The present study was conducted to characterize the binding of neurotransmitter receptors (dopamine D(2), serotonin 5-HT(2), histamine H(1), adrenaline alpha(1) and muscarine M(l) receptors) in the rat's brain after the oral administration of haloperidol, risperidone, and olanzapine. Haloperidol at 1 and 3 mg/kg displayed significant activity to bind the D(2) receptor (increase in the Kd value for [(3)H]raclopride binding) in the corpus striatum with little change in the activity toward the 5-HT(2) receptor (binding parameters for [(3)H]ketanserin). In contrast, risperidone (0.1-3 mg/kg) showed roughly 30 times more affinity for the 5-HT(2) receptor than D(2) receptor. Also, olanzapine (1-10 mg/kg) was most active toward the H(1) receptor in the cerebral cortex, corpus striatum, and hippocampus, was less active in binding 5-HT(2) and D(2) receptors, and showed the least affinity for alpha(1) and M(1) receptors. In conclusion, haloperidol and risperidone administered orally selectively bind D(2) and 5-HT(2) receptors, respectively, in the rat brain, while olanzapine binds H(1), 5-HT(2), and D(2) receptors more than alpha(1) and M(1) receptors.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
HaloperidolDopamine D2 receptorProteinHumans
Yes
Antagonist
Details
Olanzapine5-hydroxytryptamine receptor 2AProteinHumans
Yes
Antagonist
Details
OlanzapineAlpha-1B adrenergic receptorProteinHumans
Unknown
Antagonist
Details
OlanzapineDopamine D2 receptorProteinHumans
Yes
Antagonist
Details
OlanzapineHistamine H1 receptorProteinHumans
Unknown
Antagonist
Details
OlanzapineMuscarinic acetylcholine receptor M1ProteinHumans
Unknown
Antagonist
Details